Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Important note:

The S(P)EAR Committee reviews all reported incidents once a week. If you have a rapid alert that needs to be shared with the community quickly, we recommend to send a separate e-mail to the WMDA office (sear-spear@wmda.info) or call us at: +31 88 505 7900.

Serious (Product) Events and Adverse Reactions: S(P)EAR

The
Panel
borderColor#00acc8
titleColor#ffffff
titleBGColor#00acc8
titleSerious Product Events and Adverse Reactions - SPEAR
for WMDA member organisations

to report Serious (Product) Events and Adverse Reactions – S(P)EARs – to the WMDA. To access the reporting system, you login with your email address and password. If you do not have a password, contact the WMDA office

Aim

  • To gain insight in the occurrence of serious events and adverse effects in relation to blood stem cell donation by unrelated donors and blood stem cell collection/processing from unrelated donors.

Purpose

  • To collect and

analyze
  • analyse information on recipient and donor serious adverse events (SAE) and reactions which affect donors and/or products from all WMDA stem

cell
donor
  • cell donor registries and cord blood banks.

  • To follow a rapid alert system for disseminating information on SAE/R to all members of the international community in contact with allogeneic donors and patients.

Image Removed

*See for more graphs the Annual Report of 2018
Warning
titleImportant note on Rapid Alerts

The SPEAR Committee reviews all reported incidents once a week. If you have a rapid alert that needs to be shared with the community quickly, we urge you to submit it via the online reporting tool and to immediately send an e-mail to sear-spear@wmda.info or call us on: +31 88 505 7900.

In case of recall or big risks for future donations or transfusions a report can be submitted as a rapid alert. This includes, but is not limited to:

  • any prohibition or restriction imposed by the competent authority/health authorities of any country in which the stem cell product is provided or transplanted;
  • donor death;